Radiant Innovation

Radiant Innovation Capital Intensity

The Capital Intensity Ratio of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is 222.23 %. In the previous year, Capital Intensity Ratio was 222.44 % — a change of -0.10% (lower).

Capital Intensity

222.23 %

YoY

-0.10%

Last updated:

Capital Intensity Ratio of Radiant Innovation is 2025 222.23 % . Capital Intensity Ratio of Radiant Innovation was 2024 222.44 % . It decreases by -0.10% lower compared to the previous year.

The Radiant Innovation Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
97.69 TWD
Jan 1, 2019
99.79 TWD
Jan 1, 2020
73.55 TWD
Jan 1, 2021
125.90 TWD
Jan 1, 2022
197.80 TWD
Jan 1, 2023
234.00 TWD
Jan 1, 2024
222.44 TWD
Jan 1, 2025
222.23 TWD
The Radiant Innovation Capital Intensity history
YEARCapital IntensityYoY
222.23 %-0.10%
222.44 %-4.94%
234.00 %+18.30%
197.80 %+57.11%
125.90 %+71.17%
73.55 %-26.29%
99.79 %+2.15%
97.69 %-6.39%
104.35 %+5.81%
98.63 %+0.55%
98.09 %-16.90%
118.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Capital Intensity Ratio of Radiant Innovation is 222.23 % in 2025.

Capital Intensity Ratio of Radiant Innovation changed from 222.44 % to 222.23 %, representing a -0.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Radiant Innovation

All Key Metrics — Radiant Innovation